Tremfya Shows Significant BASDAI Improvement Versus Placebo in Phase 4 Study
Johnson & Johnson said Tremfya showed statistically significant improvement in BASDAI score versus placebo in a Phase 4 study.
Johnson & Johnson said Tremfya showed statistically significant improvement in BASDAI score versus placebo in a Phase 4 study.